Pharmacokinetic determinants of cocaine's differential effects on locomotor and operant behavior

European Journal of Pharmacology

Volumn 381, Issue 2-3, 1999, Pages 85-92

  Lau, Chyan E ^a   Wang, Yamei ^a   Sun, Lei ^a   Lobarinas, Edward ^a   Wang, Qiao ^a   Nguyen, Kim Ngoc ^a   Falk, John L ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Cocaine, intravenous; Fixed ratio schedule; Locomotor activity, spontaneous; Operant behavior; Pharmacodynamics; Pharmacokinetics

Indexed keywords

COCAINE;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG HALF LIFE; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; MALE; MODELS, BIOLOGICAL; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; TIME FACTORS;

EID: 0032705458     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00571-3     Document Type: Article

References (27)

1. Akaike H. A new look at the statistical model identification. IEEE Trans. Autom. Control. 19:1974;716-723.
2. Ambre J.J., Belknap S.M., Nelson J., Ruo T.I., Shin S., Atkinson A.J. Acute tolerance to cocaine in humans. Clin. Pharmacol. Ther. 44:1988;1-8.
3. Bedford J.A., Borne R.F., Wilson M.C. Comparative behavioral profile of cocaine and norcocaine in rats and monkeys. Pharmacol. Biochem. Behav. 13:1980;69-75.
4. Benuck M., Lajtha A., Reith M.E.A. Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J. Pharmacol. Exp. Ther. 243:1987;144-149.
5. Falk J.L., Ma F., Lau C.E. Chronic oral cocaine self-administration: pharmacokinetics and effects on spontaneous and discriminative motor functions. J. Pharmacol. Exp. Ther. 257:1991;457-465.
6. Harris R.A., Snell D., Loh H.H. Effects of stimulants, anorectics, and related drugs on schedule-controlled behavior. Psychopharmacology. 56:1978;49-55.
7. Hudson R.J., Stanski D.R., Saidman L.J., Meathe E. A model for studying depth of anesthesia and acute tolerance to thiopental. Anesthesiology. 59:1983;302-308.
8. Hutchaleelaha A., Sukbuntherng J., Mayersohn M. Simple apparatus for serial blood sampling in rodents permitting simultaneous measurement of locomotor activity as illustrated with cocaine. J. Pharmacol. Toxicol. Methods. 37:1997;9-14.
9. Kleven M.S., Woolverton W.L. Effects of continuous cocaine administration on schedule-controlled behavior in rhesus monkeys. Behav. Pharmacol. 2:1991;471-480.
10. Lau C.E., Falk J.L. Tolerance to oral and IP caffeine: locomotor activity and pharmacokinetics. Pharmacol. Biochem. Behav. 48:1994;337-344.
11. Lau C.E., Heatherington A.C. Pharmacokinetic-pharmacodynamic modeling of stimulatory and sedative effects of alprazolam: timing performance deficits. J. Pharmacol. Exp. Ther. 283:1997;1119-1129.
12. Lau C.E., Wang J. Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics. Psychopharmacology. 126:1996;115-124.
13. Lau C.E., Imam A., Ma F., Falk J.L. Acute effects of cocaine on spontaneous and discriminative motor functions: relation to route of administration and pharmacokinetics. J. Pharmacol. Exp. Ther. 257:1991;444-456.
14. Lau C.E., Ma F., Wang Y., Smith C. Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics. Psychopharmacology. 126:1996;241-248.
15. Lau C.E., Wang Y., Falk J.L. Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: independent interaction of alprazolam and caffeine. J. Pharmacol. Exp. Ther. 281:1997;1013-1029.
16. Lau C.E., Wang Y., Ma F. Pharmacokinetic-pharmacodynamic modeling of the coexistence of stimulatory and sedative components for midazolam. Eur. J. Pharmacol. 346:1998;131-144.
17. Lau C.E., Ma F., Foster D.M., Falk J.L. Pharmacokinetic-pharmacodynamic modeling of the psychomotor stimulant effect of cocaine after intravenous administration: timing performance deficits. J. Pharmacol. Exp. Ther. 288:1999;535-543.
18. Laurijssens B.E., Greenblatt D.J. Pharmacokinetic-pharmacodynamic relationships for benzodiazepines. Clin. Pharmacokinet. 30:1996;52-76.
19. MacPhail R.C., Seiden L.S. Time course for the effects of cocaine on fixed-ratio water-reinforced responding in rats. Psychopharmacologia (Berlin). 44:1975;1-4.
20. Noe D.A., Kumor K.M. A pharmacokinetic-pharmacodynamic model of heart rate during cocaine administration in humans. Clin. Pharmacol. Ther. 49:1991;426-432.
21. Reith M.E.A., Benuck M., Lajtha A. Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J. Pharmacol. Ther. 243:1987;281-287.
22. Smith J.B. Situational specificity of tolerance to decreased operant responding by cocaine. Pharmacol. Biochem. Behav. 36:1990;473-477.
23. Spealman R.D., Goldberg S.R., Kelleher R.T., Goldberg D.M., Charlton J.P. Some effects of cocaine and two cocaine analogs on schedule-controlled behavior of squirrel monkeys. J. Pharm. Exp. Ther. 202:1977;500-509.
24. Van Harren F. Differential effects of cocaine on high and low response rates maintained with and without rate requirements. Behav. Pharmacol. 3:1992;435-441.
25. Wang Y., Lau C.E. Caffeine has similar pharmacokinetics and behavioral effects via the IP and PO routes of administration. Pharmacol. Biochem. Behav. 60:1998;271-278.
26. Weiss B., Laties V.C., Siegel L., Goldstein D.A. Computer analysis of serial interactions in spaced responding. J. Exp. Anal. Behav. 9:1966;619-626.
27. Woolverton W.L., Kandel D., Schuster C.R. Effects of repeated administration of cocaine on schedule-controlled behavior of rats. Pharmacol. Biochem. Behav. 9:1978;327-337.